Search

everythinglearnresearchcommunity

for

Search:↓

Different prostate cancer treatments have similar risks of secondary cancers and related mortality when considering patient age and smoking history.

Finasteride's effects on prostate cancer are not clear from this text.

New treatments are making advanced prostate cancer management more complex but also more hopeful.

Men and women may have different risks of getting skin cancer.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Giving docetaxel weekly at 40 mg/m² is manageable and has low toxicity for cancer patients.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

Finasteride does not prevent bladder cancer.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

Minoxidil increases calcium levels and kills prostate cancer cells independently of calcium.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Electric pulse treatments for breast cancer show promise in being safer and more effective, with fewer side effects.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

Heavy metals like arsenic, cadmium, and lead can increase cancer risk and worsen outcomes.

Flubendazole in a nanoemulsion can potentially treat lung cancer and cryptococcal meningitis effectively and safely.

The revised manuscript on how inflammation affects cancer stem cells was accepted after addressing issues with clarity and detail.

The revised study on how inflammation affects cancer stem cells was accepted after improving clarity and structure.

Serum triglyceride levels are not linked to prostate cancer risk.

Low dose finasteride causes only small changes in PSA levels in older men with BPH.

Using a single PSA level to decide on a prostate biopsy is not effective; a more personalized approach considering various factors is recommended.

Dutasteride may help treat prostate cancer by causing cancer cells to shrink and die.

Examining more lymph nodes can improve survival rates in breast cancer patients without lymph node involvement.

Coumarin derivatives show promise as anti-estrogenic agents for treating breast cancer, with some in clinical trials.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

Enhancers and super-enhancers are key in controlling specific gene activity and can play a role in cancer development.